New key publication:Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion.
04 November 2016

Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion
Highlights
- Cholesterol is excreted in humans via biliary and direct transintestinal secretion
- In humans, TICE accounts for 35% of fecal cholesterol excretion
- Ezetimibe increases fecal cholesterol excretion primarily by activation of TICE
- The cholesterol transporter ABCG5/G8 mediates most of the TICE flux
Editorial: Of TICE in Men .
Last modified:13 January 2017 07.30 a.m.
More news
-
02 June 2026
Nominees Ben Feringa Impact Award 2026 | Interviews
-
26 May 2026
Babs Gons, new guest writer at the UG
-
26 May 2026
Student teams compete with self-driving cars